Bone Biologics (BBLG) Gains from Sales and Divestitures (2016)
Historic Gains from Sales and Divestitures for Bone Biologics (BBLG) over the last 1 years, with Q4 2016 value amounting to -$791139.0.
- Bone Biologics' Gains from Sales and Divestitures changed N/A to -$791139.0 in Q4 2016 from the same period last year, while for Dec 2016 it was -$791139.0, marking a year-over-year change of. This contributed to the annual value of -$791139.0 for FY2016, which is N/A changed from last year.
- Latest data reveals that Bone Biologics reported Gains from Sales and Divestitures of -$791139.0 as of Q4 2016.
- In the past 5 years, Bone Biologics' Gains from Sales and Divestitures ranged from a high of -$791139.0 in Q4 2016 and a low of -$791139.0 during Q4 2016